Boosted by rising health awareness, demand for tocotrienol in dietary supplements and cosmetics is increasing. Key regions like China and Japan lead due to health benefits, with major players like BASF SE driving industry innovation. Boosted by rising health awareness, demand for tocotrienol in dietary supplements and cosmetics is increasing. Key regions like China and Japan lead due to health ...
Synthetic Vitamin E Market Decline Amid Supply Chain Challenges: A 2023 Market report revealed a sharp 19.5% drop in the global synthetic vitamin E market, mainly due to low prices and destocking. Synthetic Vitamin E Market Decline Amid Supply Chain Challenges: A 2023 Market report revealed a sharp 19.5% drop in the global synthetic vitamin E market, mainly due to low prices and destocking.
Der Chemiekonzern BASF DE000BASF111 steht auf der Liste der Unternehmen, bei denen das Analysehaus Warburg Research für 2025 eine Gewinnwarnung befürchtet.
Markets remained volatile in May 2025 amid ongoing trade tensions and mixed signals from Washington and Wall Street. While U.S.-China talks quietly resumed, tariffs persisted and business sentiment stayed cautious, contributing to investor uncertainty. May's investments added $111 in annual dividends, keeping me on track with my goal of $100+ monthly income growth and a 7.4% yield on cost.
The global recycled elastomers market is fragmented and characterized by numerous manufacturers which hold modest market share. Key players, including have established dominance in the global recycled elastomers market by continuously innovating and expanding their product offerings. Moreover, major vendors have strategically implemented innovative technologies to maintain their market position...
Das Analysehaus Jefferies hat das Kursziel für die Aktien von BASF DE000BASF111 von 52 auf 47 Euro gesenkt und die Papiere von "Buy" auf "Hold" abgestuft.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.